Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Predictive Genetic Testing And Consumer Genomics Market By 2029?
The genetic testing and consumer genomics market size has observed significant expansion in recent years. Projections show that it will rise from $7.83 billion in 2024 to $9.07 billion in 2025, achieving a compound annual growth rate (CAGR) of 15.7%. This historical growth can be linked to a growing focus on early disease detection and risk assessment, increasing affordability and accessibility of genetic testing technologies, growing consumer interest in ancestry and trait analysis, increasing expansion of telehealth platforms, and rising prevalence of chronic and hereditary diseases.
The genetic testing and consumer genomics market size is forecast to experience rapid expansion over the next few years, projected to reach $16.14 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.5%. This growth within the forecast timeframe can be attributed to an increasing demand for personalized healthcare and preventive medicine, the growing accessibility of direct-to-consumer genetic testing kits, a rise in the adoption of genomics for clinical decision-making, escalating investments in biotechnology and genetic research, and increased government support for genomic research and precision medicine initiatives. Significant trends expected during this period include advancements in next-generation sequencing, the integration of AI and machine learning into genetic data analysis, developments in portable and at-home testing technologies, the incorporation of genetic data with electronic health records, and innovations in microarray technology.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp
Which Drivers Are Shaping The Predictive Genetic Testing And Consumer Genomics Industry’s Market Share?
The increasing understanding of personalized medicine is anticipated to stimulate the expansion of the predictive genetic testing and consumer genomics market moving forward. Personalized medicine defines a medical methodology that customizes treatment and prevention plans based on an individual’s genetic makeup, lifestyle, and environmental factors. The awareness regarding personalized medicine is growing because it enhances treatment effectiveness by matching therapies to a patient’s specific biological characteristics. Predictive genetic testing and consumer genomics contribute to personalized medicine by identifying genetic risks and traits, thus enabling customized prevention, early diagnosis, and treatment strategies founded on an individual’s genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, noted that the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, which represents an increase from 6 approvals in 2022. Therefore, the heightened awareness about personalized medicine is propelling the growth of the predictive genetic testing and consumer genomics market.
What Are The Emerging Segments Gaining Attention In The Predictive Genetic Testing And Consumer Genomics Market?
The predictive genetic testing and consumer genomics market covered in this report is segmented –
1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing
3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting
4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases
5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)
Subsegments:
1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics
2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk
3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization
4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening
Which Key Trends Are Expected To Influence The Predictive Genetic Testing And Consumer Genomics Market In The Coming Years?
Leading companies in the predictive genetic testing and consumer genomics market are concentrating on developing innovative solutions, such as consumer genomics insight services, to furnish individuals with personalized health information and facilitate the early identification of genetic risks. A consumer genomics insight service is defined as a direct-to-consumer genetic testing solution that examines an individual’s DNA to provide insights into ancestry, potential health risks, traits, and overall wellness, without the need for a medical prescription. For instance, in November 2022, Strand Life Sciences Private Limited, an India-based technology company, introduced Strand Genomic Wellness to offer individualized health insights. This allows individuals to comprehend their genetic predisposition to various diseases, thereby supporting proactive health management and preventive care using genomic information. The primary advantage lies in enabling individuals and their physicians to make informed lifestyle and medical decisions based on unique genetic profiles.
Who Are The Major Companies Operating In The Predictive Genetic Testing And Consumer Genomics Market?
Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation.
Download The Full Report For Exclusive Market Findings:
How Does The Predictive Genetic Testing And Consumer Genomics Market Perform Across Key Geographic Regions?
North America was the largest region in the predictive genetic testing and consumer genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Predictive Genetic Testing And Consumer Genomics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25884&type=smp
Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2025, By The Business Research Company
Consumer Genomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report
Direct To Consumer Dtc Genetic Testing Global Market Report 2025
Genetic Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model